FTC (US Federal Trade Commission) seeks more information on Physio-Control purchase:
This article was originally published in Clinica
The US Federal Trade Commission has asked Medtronic for further information in connection with its proposed acquisition of Physio-Control. Medtronic says this is "not expected to delay timely completion of the transaction". Separately, Medtronic saw a 3% increase in net earnings of $146.5 million in the first quarter. Revenues were $652.3 million, up 4% on a comparable basis. The figures confirm Medtronic's announcement earlier this month, when the company said its results would be below both its own and analysts' expectations (see Clinica No 821, p 6).
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.